<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000306486">
  <TermName>agnogenic myeloid metaplasia</TermName>
  <TermPronunciation>(ag-noh-JEH-nik MY-eh-loyd meh-tuh-PLAY-zhuh)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A progressive, chronic disease in which the bone marrow is replaced by fibrous tissue and blood is made in organs such as the liver and the spleen, instead of in the bone marrow. This disease is marked by an enlarged spleen and progressive anemia. Also called chronic idiopathic myelofibrosis, idiopathic myelofibrosis, myelosclerosis with myeloid metaplasia, and primary myelofibrosis.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000710152" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;agnogenic myeloid metaplasia&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000710151" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;metaplasia mieloide agnógena&quot;" language="es" id="_4"/>
  <SpanishTermName>metaplasia mieloide agnógena</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Enfermedad crónica progresiva en la que la médula ósea es reemplazada por tejido fibroso y la sangre se produce en órganos tales como el hígado y el bazo, en vez de la médula ósea. Esta enfermedad se caracteriza por el agrandamiento del bazo y anemia progresiva. También se llama mieloesclerosis con metaplasia mieloide, mielofibrosis idiopática, mielofibrosis idiopática crónica y mielofibrosis primaria.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-05-23</DateFirstPublished>
  <DateLastModified>2007-04-26</DateLastModified>
</GlossaryTerm>
